|
Volcano Corporation Schedules Second Quarter Conference Call, Webcast
|
 |
 |
|
July 20, 2010 -- San
Diego -- Volcano Corporation (Nasdaq: VOLC), a leading developer and
manufacturer of precision intravascular therapy guidance tools
designed to enhance the diagnosis and treatment of coronary and
peripheral vascular disease, today announced that it will report
its operating results for the second quarter and first six months
of fiscal 2010 on Friday, July 30. |
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 5:30 a.m., Pacific Daylight Time (8:30 a.m., Eastern Daylight Time), Friday, July 30, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer. The teleconference can be accessed by calling (631) 291-4555, passcode 85477811. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available through the company's website at www.volcanocorp.com.
A replay of the conference call will be available through Friday, August 6, at (706) 645-9291, passcode 85477811, and via the company's website.
About Volcano Corporation
Volcano Corporation (NASDAQ: VOLC) offers a broad
suite of devices designed to facilitate endovascular procedures, enhance the
diagnosis of vascular and structural heart disease and guide optimal therapies.
The company's intravascular ultrasound (IVUS) product line includes consoles
that can be integrated directly into virtually any modern cath lab. Volcano
IVUS offers unique features, including both single-use digital and rotational
IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS
tissue characterization and ChromaFlo(R). Volcano also provides Image-Guided
Therapy products that combine the imaging capability of IVUS with cardiovascular
therapeutic devices. Volcano has Physiology consoles and single-use pressure
and flow guide wires. Currently, more than 5,200 Volcano IVUS and Physiology
systems are installed worldwide, with approximately half of Volcano's revenues
coming from outside the United States. Volcano is developing a line of ultra-high
resolution Optical Coherence Tomography (OCT) systems and catheters, Forward-Looking
Imaging catheters and Microcatheters. Volcano's wholly-owned subsidiary, Axsun
Technologies, develops and manufactures optical monitors, lasers and optical
engines used in telecommunications, medical imaging, spectroscopy and other
industrial applications. For more information, visit the company's website
at www.volcanocorp.com.
Source: Volcano
Corporation
|
